AVE Science & Technology Co

AVE Science & Technology Co EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of AVE Science & Technology Co (688067.SS) as of Nov 16, 2026 is 64.09. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was 59.85 — a change of 7.08% (higher).

EV/EBITDA

64.09

YoY

7.08%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of AVE Science & Technology Co is 2025 64.09 . EV/EBITDA (Enterprise Value to EBITDA) of AVE Science & Technology Co was 2024 59.85 . It decreases by 7.08% higher compared to the previous year.

The AVE Science & Technology Co EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2018
58.30 CNY
Jan 1, 2019
31.69 CNY
Jan 1, 2020
49.97 CNY
Jan 1, 2021
43.79 CNY
Jan 1, 2022
71.12 CNY
Jan 1, 2023
63.47 CNY
Jan 1, 2024
59.85 CNY
Jan 1, 2025
64.09 CNY
The AVE Science & Technology Co EV/EBITDA history
YEAREV/EBITDAYoY
64.09+7.08%
59.85-5.70%
63.47-10.76%
71.12+62.40%
43.79-12.37%
49.97+57.72%
31.69-45.65%
58.30-5.80%
61.89-27.61%
85.49-32.81%
127.24-31.91%
186.86—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AVE Science & Technology Co Stock analysis

What does AVE Science & Technology Co do? AVE Science & Technology Co., Ltd. generates revenue through the research, development, production, sale, and service of clinical testing and analysis instruments. Its main products include urine formed component analyzer, urine dry chemistry analyzer, urine full item automatic analyzer, automatic stool analyzer, automatic body fluid analyzer, reproductive tract secretion analyzer, and special supporting in vitro diagnostic reagents and medical consumables. These products are primarily sold to inspection departments within medical and health institutions in both domestic and overseas markets. The company serves healthcare facilities that require diagnostic equipment for laboratory testing and patient care. The firm's product portfolio targets healthcare institutions seeking advanced diagnostic tools for efficient clinical analysis. By focusing on specialized instruments like urine and stool analyzers, AVE Science & Technology addresses specific needs in medical testing departments. The company's domestic and international distribution channels ensure broad market access for its diagnostic solutions. AVE Science & Technology's revenue streams are derived from the sale of its comprehensive range of clinical testing instruments and related consumables. The company's domestic market presence and overseas sales contribute to its overall business performance. Its products support routine diagnostic procedures across various healthcare settings, driving consistent demand for its equipment and reagents. AVE Science & Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AVE Science & Technology Co stock

EV/EBITDA (Enterprise Value to EBITDA) of AVE Science & Technology Co is 64.09 in 2025.

EV/EBITDA (Enterprise Value to EBITDA) of AVE Science & Technology Co changed from 59.85 to 64.09, representing a 7.08% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) AVE Science & Technology Co since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s AVE Science & Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — AVE Science & Technology Co

All Key Metrics — AVE Science & Technology Co